[1]
C. Pittayawonganon, N. Pisitpayat, S. Kripattanapong, P. Doungngern, and C. Jitpeera, “Effectiveness and Safety of Long-acting Antibody (LAAB) to Prevent COVID-19 among High-risk Population in Thailand: a 6-month Retro-prospective Cohort Study”, OSIR, vol. 17, no. 3, pp. 155–164, Sep. 2024.